Your browser doesn't support javascript.
loading
Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder.
Schwarz, Emanuel; Doan, Nhat Trung; Pergola, Giulio; Westlye, Lars T; Kaufmann, Tobias; Wolfers, Thomas; Brecheisen, Ralph; Quarto, Tiziana; Ing, Alex J; Di Carlo, Pasquale; Gurholt, Tiril P; Harms, Robbert L; Noirhomme, Quentin; Moberget, Torgeir; Agartz, Ingrid; Andreassen, Ole A; Bellani, Marcella; Bertolino, Alessandro; Blasi, Giuseppe; Brambilla, Paolo; Buitelaar, Jan K; Cervenka, Simon; Flyckt, Lena; Frangou, Sophia; Franke, Barbara; Hall, Jeremy; Heslenfeld, Dirk J; Kirsch, Peter; McIntosh, Andrew M; Nöthen, Markus M; Papassotiropoulos, Andreas; de Quervain, Dominique J-F; Rietschel, Marcella; Schumann, Gunter; Tost, Heike; Witt, Stephanie H; Zink, Mathias; Meyer-Lindenberg, Andreas.
Afiliação
  • Schwarz E; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. emanuel.schwarz@zi-mannheim.de.
  • Doan NT; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Pergola G; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Westlye LT; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Kaufmann T; Department of Psychology, University of Oslo, Oslo, Norway.
  • Wolfers T; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Brecheisen R; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Quarto T; Donders Center for Cognitive Neuroimaging, Radboud University, Nijmegen, The Netherlands.
  • Ing AJ; Maastricht University Medical Center, Maastricht, The Netherlands.
  • Di Carlo P; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Gurholt TP; Cognitive Brain Research Unit, Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Harms RL; Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Noirhomme Q; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Moberget T; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Agartz I; Brain Innovation B.V., Maastricht, The Netherlands.
  • Andreassen OA; Brain Innovation B.V., Maastricht, The Netherlands.
  • Bellani M; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Bertolino A; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Blasi G; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm County Council, Stockholm, Sweden.
  • Brambilla P; Department of Psychiatry Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Buitelaar JK; Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Cervenka S; Section of Psychiatry, Azienda Ospedaliera Universitaria Integrata Verona, Verona, VR, Italy.
  • Flyckt L; Department of Neurosciences, Biomedicine and Movements Sciences, University of Verona, Verona, VR, Italy.
  • Frangou S; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Franke B; Institute of Psichiatry, Policlinico Bari, Azienda Ospedaliero Universitaria Consorziale Policlinico Bari, Bari, BA, Italy.
  • Hall J; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Heslenfeld DJ; Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy.
  • Kirsch P; Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
  • McIntosh AM; Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
  • Nöthen MM; Karakter Child and Adolescent Psychiatry University Center, Nijmegen, The Netherlands.
  • Papassotiropoulos A; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm County Council, Stockholm, Sweden.
  • de Quervain DJ; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm County Council, Stockholm, Sweden.
  • Rietschel M; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Schumann G; Donders Institute for Brain, Cognition and Behaviour, Radboudumc, Nijmegen, The Netherlands.
  • Tost H; Departments of Human Genetics and Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Witt SH; Neuroscience and Mental Health Research Institute, Cardiff University, Maindy Road, Cardiff, CF24 4HQ, UK.
  • Zink M; Department of Cognitive Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Meyer-Lindenberg A; Department of Clinical Psychology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Transl Psychiatry ; 9(1): 12, 2019 01 17.
Article em En | MEDLINE | ID: mdl-30664633
ABSTRACT
Schizophrenia is a severe mental disorder characterized by numerous subtle changes in brain structure and function. Machine learning allows exploring the utility of combining structural and functional brain magnetic resonance imaging (MRI) measures for diagnostic application, but this approach has been hampered by sample size limitations and lack of differential diagnostic data. Here, we performed a multi-site machine learning analysis to explore brain structural patterns of T1 MRI data in 2668 individuals with schizophrenia, bipolar disorder or attention-deficit/ hyperactivity disorder, and healthy controls. We found reproducible changes of structural parameters in schizophrenia that yielded a classification accuracy of up to 76% and provided discrimination from ADHD, through it lacked specificity against bipolar disorder. The observed changes largely indexed distributed grey matter alterations that could be represented through a combination of several global brain-structural parameters. This multi-site machine learning study identified a brain-structural signature that could reproducibly differentiate schizophrenia patients from controls, but lacked specificity against bipolar disorder. While this currently limits the clinical utility of the identified signature, the present study highlights that the underlying alterations index substantial global grey matter changes in psychotic disorders, reflecting the biological similarity of these conditions, and provide a roadmap for future exploration of brain structural alterations in psychiatric patients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtorno do Deficit de Atenção com Hiperatividade / Transtorno Bipolar / Substância Cinzenta Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtorno do Deficit de Atenção com Hiperatividade / Transtorno Bipolar / Substância Cinzenta Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article